Latest Underwriting News

Steadfast Group reported a robust FY25 with underlying NPAT rising 17.2% to $295.5 million, driven by strong organic growth and strategic acquisitions in the US and UK. The insurer broker continues to invest in technology and international expansion while raising dividends.

Steadfast Group has reported a robust 17.2% increase in underlying net profit after tax for FY25, alongside a 14% rise in its fully franked final dividend, underpinned by both organic growth and strategic acquisitions.

Aeeris Ltd reported a 27.7% revenue increase to $4.36 million for FY25, driven by proprietary platform launches and expanded client contracts, while posting a net loss of $632,731. The company is poised for operational scale and cash flow positivity in FY26.

Camplify Holdings Limited reported a 12.3% revenue decline to $42.1 million and a near doubling of net loss to $15.8 million in FY25, reflecting a year of strategic transformation including the launch of its MyWay protection product and completion of European platform integration.

Cyprium Metals has secured A$80 million through a placement and entitlement offer to fund the restart of its Nifty Copper Complex and reduce existing debt, backed by strong institutional support.

Control Bionics Limited has announced a $2.06 million non-renounceable rights issue to fund the commercial expansion of its NeuroStrip device and bolster NeuroNode operations. The capital raise is underwritten to approximately $1.15 million by major shareholders and strategic partners.

Lynas Rare Earths has launched a fully underwritten A$750 million equity raising to fund its ambitious Towards 2030 growth strategy, aiming to expand rare earths production and downstream capabilities outside China.

Optiscan Imaging Limited has launched a $17.75 million fully underwritten entitlement offer to fund clinical trials, regulatory approvals, and product development. Peters Investments underwrites the offer, potentially increasing its stake to nearly 39%.

Optiscan Imaging Ltd has launched a fully underwritten $17.75 million entitlement offer to fund clinical trials and regulatory clearances for its medical devices, marking a pivotal step in its transition to a commercial medical device manufacturer.

Pengana International Equities has acknowledged breaching ASX disclosure rules by sharing details of a new private credit strategy with media before official announcement, prompting a policy overhaul.

MA Credit Income Trust (ASX, MA1) has announced a $190.5 million non-renounceable entitlement offer at a 3.4% discount, aiming to bolster its private credit investments across asset-backed, direct asset, and corporate lending sectors.

Domino’s Pizza Enterprises reported a modest dip in FY25 sales and earnings amid a strategic reset focused on cost efficiency and franchisee support. The company aims to rebuild momentum through targeted reinvestment and operational simplification.